Article
Orthopedics
Jack M. Haglin, Jaymeson R. Arthur, David G. Deckey, Michael L. Moore, Justin L. Makovicka, Mark J. Spangehl
Summary: The study found that from 2011 to 2017, the average Medicare reimbursement to hospitals for TJA procedures decreased, while hospital charges increased. These findings are important for the development of more acceptable reimbursement models in arthroplasty care in the future as alternative payment models continue to be evaluated and developed.
JOURNAL OF ARTHROPLASTY
(2021)
Article
Health Care Sciences & Services
Edwine Barasa, Inke Mathauer, Evelyn Kabia, Nkoli Ezumah, Rahab Mbau, Ayako Honda, Fahdi Dkhimi, Obinna Onwujekwe, Hoang Thi Phuong, Kara Hanson
Summary: Provider payment methods play a key role in influencing healthcare provider behavior and affecting health system objectives. When healthcare providers receive multiple funding flows, they may prioritize certain funding flows over others, leading to shifts in resources, services, and costs. Aligning the incentives generated by multiple funding flows is crucial for achieving health system goals.
HEALTH POLICY AND PLANNING
(2021)
Article
Orthopedics
Charles F. S. Locke, Ronald L. Hirsch, Edward P. Hu, Andrew H. Hughes, James R. Ficke
Summary: This study investigated the differences in hospital payments for common orthopaedic/spinal procedures under outpatient and inpatient status in the DRG/APC system. It compared these differences with the payment differences in Maryland hospitals under the global budget revenue model.
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
(2022)
Article
Environmental Sciences
Li Xiang, Zhengdong Zhong, Junnan Jiang
Summary: This study theoretically and empirically verifies that large hospitals are more likely to increase service volume and small hospitals are more likely to transfer costs under the influence of RGB-FPS. Chinese public hospitals' response to RGB-FPS is similar to that of private hospitals.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
(2022)
Article
Economics
Timothy T. Brown, James C. Robinson
Article
Health Care Sciences & Services
James C. Robinson, Timothy T. Brown, Christopher Whaley
Article
Health Care Sciences & Services
James C. Robinson
Article
Medicine, General & Internal
James C. Robinson, Christopher M. Whaley, Timothy T. Brown
NEW ENGLAND JOURNAL OF MEDICINE
(2017)
Editorial Material
Medicine, General & Internal
James C. Robinson
JAMA INTERNAL MEDICINE
(2017)
Editorial Material
Medicine, General & Internal
James C. Robinson, Scott Howell, Steven D. Pearson
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2018)
Editorial Material
Medicine, General & Internal
James C. Robinson
NEW ENGLAND JOURNAL OF MEDICINE
(2020)
Editorial Material
Medicine, General & Internal
James C. Robinson
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2020)
Editorial Material
Medicine, General & Internal
James C. Robinson
Summary: This viewpoint discusses the shift towards government funding of drug development during the COVID-19 pandemic, arguing that sustained public investment is necessary for affordable drug prices and U.S. global leadership.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2021)
Article
Health Care Sciences & Services
Scott Howell, Perry T. Yin, James C. Robinson
Summary: The launch of high-price but innovative drugs has led to increased efforts to manage utilization and spending from payers and support patient access and sales from pharmaceutical manufacturers. Existing literature estimates that approximately $93.3 billion is spent annually by payers, manufacturers, physicians, and patients on managing utilization.
Article
Health Care Sciences & Services
James C. Robinson, Quentin Jarrion
Summary: France has a single-payer health insurance system that relies on decentralized market negotiations between hospitals and manufacturers to establish prices for biologics. Biosimilars are used to stimulate competition and drive price reductions, with biosimilar launches associated with reductions in prices for reference biologics and other related biologics.
Article
Health Care Sciences & Services
James C. Robinson, Christopher M. Whaley, Timothy T. Brown
Summary: Research has shown that Blue Cross Blue Shield health plans paid double for cancer infusion drugs in hospital outpatient departments compared to physician offices in 2019. Shifting infusion care to nonhospital settings could result in significant savings for insurers, but would also increase cost-sharing burdens for patients.
Editorial Material
Medicine, General & Internal
James C. Robinson
Summary: The price of Aducanumab responds to key features of the physician-administered drug market environment, providing valuable information for the drug pricing policy debate.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Medicine, General & Internal
James C. Robinson, Christopher Whaley, Timothy T. Brown, Sanket S. Dhruva
Article
Health Care Sciences & Services
Fabian Berkemeier, Christopher Whaley, James C. Robinson
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY
(2019)